MyFinsight
Home
About
Contact
kytx: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, KYTX has $187,156K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Subscribe for Financial Insights
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
187,156
226,508
Total stockholders' equity
151,946
184,377
Total liabilities and stockholders' equity
187,156
226,508
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Subscribe for Financial Insights
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Property and equipment,
gross
$5,376K
Prepaid expenses and
other current assets
$3,787K
Available-for-sale marketable
securities
$136,974K
Cash and cash
equivalents
$34,164K
Other non-current
assets
$5,358K
Finance lease
right-of-use assets
$212K
Operating lease
right-of-use assets
$4,317K
Property and equipment,
net
$1,793K
Restricted cash
$551K
Total current assets
$174,925K
Less accumulated
depreciation
$3,583K
Total assets
$187,156K
Total liabilities and
stockholders' equity
$187,156K
Total stockholders'
equity
$151,946K
Total liabilities
$35,210K
Accumulated deficit
-$387,023K
Accumulated other
comprehensive income
$29K
Additional paid-in capital
$538,940K
Finance lease
liabilities, net of...
$8K
Operating lease
liabilities, net of...
$1,331K
Total current
liabilities
$33,871K
Finance lease
liabilities, short-term...
$190K
Operating lease
liabilities, short-term...
$3,495K
Other accrued
expenses and current...
$13,960K
Accrued license expense
- related party
$6,250K
Accrued compensation
$6,960K
Accounts payable
$3,016K
Buy me a coffee
Kyverna Therapeutics, Inc. (KYTX)
Kyverna Therapeutics, Inc. (KYTX)